loading page

Tranexamic acid use during thyroid surgery: A single centre retrospective analysis
  • Ayeshah Abdul-Hamid,
  • Andrew Carswell
Ayeshah Abdul-Hamid
Royal Berkshire NHS Foundation Trust
Author Profile
Andrew Carswell
Great Western Hospitals NHS Foundation Trust
Author Profile

Abstract

Key Points: • Tranexamic acid is an antifibrinolytic agent that has been used in variety of operations to reduce blood loss. • Post thyroidectomy haematoma can be life threatening, therefore multiple methods are used to reduce the risk of bleeding. • Tranexamic acid was given intra-operatively to 106 patients undergoing thyroid surgery. • Patients who received tranexamic acid had no return to theatre for post-operative haematoma (p=0.041). • There were no adverse events reported related to the administration of tranexamic acid.

Peer review status:UNDER REVIEW

22 Aug 2020Submitted to Clinical Otolaryngology
31 Aug 2020Assigned to Editor
31 Aug 2020Submission Checks Completed
22 Sep 2020Reviewer(s) Assigned